Format
Sort by

Send to:

Choose Destination

Results: 5

Cited In for PubMed (Select 17344346)

1.

Diversity of antibody responses to Borrelia burgdorferi in experimentally infected beagle dogs.

Baum E, Grosenbaugh DA, Barbour AG.

Clin Vaccine Immunol. 2014 Jun;21(6):838-46. doi: 10.1128/CVI.00018-14. Epub 2014 Apr 2.

2.

A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen.

Xiao S, Kumar M, Yang X, Akkoyunlu M, Collins PL, Samal SK, Pal U.

Vaccine. 2011 Jul 18;29(32):5294-303. doi: 10.1016/j.vaccine.2011.05.010. Epub 2011 May 19.

3.

One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.

LaFleur RL, Callister SM, Dant JC, Jobe DA, Lovrich SD, Warner TF, Wasmoen TL, Schell RF.

Clin Vaccine Immunol. 2010 May;17(5):870-4. doi: 10.1128/CVI.00524-09. Epub 2010 Mar 17.

4.

Humoral immune response in dogs naturally infected with Borrelia burgdorferi sensu lato and in dogs after immunization with a Borrelia vaccine.

Leschnik MW, Kirtz G, Khanakah G, Duscher G, Leidinger E, Thalhammer JG, Joachim A, Stanek G.

Clin Vaccine Immunol. 2010 May;17(5):828-35. doi: 10.1128/CVI.00427-09. Epub 2010 Mar 10.

5.

Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF.

Clin Vaccine Immunol. 2009 Feb;16(2):253-9. doi: 10.1128/CVI.00373-08. Epub 2008 Dec 3.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk